Partner Article
Northwich-based Dechra Pharmaceuticals PLC remains ‘confident’
Competitor stock shortages in the US have meant strong revenues for Northwich-based Dechra Pharmaceuticals.
The manufacturer of veterinary products has reported that group revenue has increased in this quarter by 14.3% at constant exchange rates and 6% at actual exchange rates.
The European part of the business has seen revenues fall at actual exchange rates by 3.3% however sales were positively impacted by wholesalers buying in advance of Easter.
The company said: “ We remain on track to deliver our strategic milestones and further progress has been made in the period“
This was posted in Bdaily's Members' News section by Sophia Taha .
Our Partners
Why local government is key to devolution success
Your reputation is worth more than that invoice
There is no perfect time when selling a business
What next when social media career help goes?
The psychological contract that nobody signs
Time for strategy built on the foundational economy
Why being ‘work-ready’ matters more than ever
The North's future doesn't end at Manchester
Exit or legacy? Why every owner needs a plan
Who speaks up for SMEs when giants get bigger?
The true value of HR in an AI-driven working world
What new business rates guidance means for pubs